Esprinet S.p.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was EUR 2,744.94 million compared to EUR 3,217.7 million a year ago. Net loss was EUR 24.9 million compared to net income of EUR 23.32 million a year ago. Basic loss per share from continuing operations was EUR 0.5 compared to basic earnings per share from continuing operations of EUR 0.47 a year ago. Diluted loss per share from continuing operations was EUR 0.5 compared to diluted earnings per share from continuing operations of EUR 0.47 a year ago.